Petereit, H., Tumani, H., & Zettl, U. K. (2021). Correspondence: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies. Ther Adv Neurol Disord.
Chicago-tyylinen lähdeviittausPetereit, Hela-Felicitas, Hayrettin Tumani, ja Uwe K. Zettl. "Correspondence: Humoral Immune Response to COVID-19 MRNA Vaccine in Patients With Multiple Sclerosis Treated With High-efficacy Disease-modifying Therapies." Ther Adv Neurol Disord 2021.
MLA-viitePetereit, Hela-Felicitas, Hayrettin Tumani, ja Uwe K. Zettl. "Correspondence: Humoral Immune Response to COVID-19 MRNA Vaccine in Patients With Multiple Sclerosis Treated With High-efficacy Disease-modifying Therapies." Ther Adv Neurol Disord 2021.